Journal of Clinical Endocrinology & Metabolism, Vol 66, 273-278, Copyright © 1988 by Endocrine Society

ARTICLES

Lack of hypoglycemic symptoms and decreased beta-adrenergic sensitivity in insulin-dependent diabetic patients

I Berlin, A Grimaldi, C Landault, F Zoghbi, F Thervet, AJ Puech and JC Legrand
Department of Clinical Pharmacology, Hopital Pitie-Salpetriere, Paris, France.

Plasma epinephrine, norepinephrine, and dopamine responses were studied in insulin-dependent diabetic patients at rest, on standing and during insulin-induced hypoglycemia. beta-Adrenergic sensitivity was evaluated by the isoproterenol sensitivity test. Five men who had adrenergic symptoms during hypoglycemia and no severe hypoglycemic accidents (coma, seizures) (group A) and five men who had repeated severe hypoglycemic accidents but lack of adrenergic symptoms of hypoglycemia (group B) were studied. The mean resting plasma epinephrine was lower in group B (147 +/- 22 pmol/L, SEM) than in group A (398 +/- 98 pmol/L, P less than 0.02). On standing plasma epinephrine increased significantly in both groups. During hypoglycemia blood glucose decreased identically in the two groups; plasma epinephrine and norepinephrine increased significantly and to the same extent in both groups; the mean maximal heart rate was significantly greater in group A than in group B. Isoproterenol sensitivity (defined as the dose of isoproterenol required to increase heart rate by 25 beats/min) was lower in group B (5.87 +/- 1.12 micrograms) than in group A (2.37 +/- 0.22 micrograms, P less than 0.01). The group B patients had significantly fewer hypoglycemic symptoms during insulin-induced hypoglycemia than did group A patients. We conclude that decreased beta- adrenergic sensitivity contributes to the lack of adrenergic symptoms of hypoglycemia in insulin-dependent diabetic patients.

This article has been cited by other articles:

				B. E. De Galan, P. De Mol, L. Wennekes, B. J. J. Schouwenberg, and P. Smits Preserved Sensitivity to {beta}2-Adrenergic Receptor Agonists in Patients with Type 1 Diabetes Mellitus and Hypoglycemia Unawareness J. Clin. Endocrinol. Metab., August 1, 2006; 91(8): 2878 - 2881. [Abstract] [Full Text] [PDF]

				P. E. Cryer Mechanisms of Hypoglycemia-Associated Autonomic Failure and Its Component Syndromes in Diabetes Diabetes, December 1, 2005; 54(12): 3592 - 3601. [Abstract] [Full Text] [PDF]

				B. E. de Galan, S. J. Rietjens, C. J. Tack, S. P. van der Werf, C. G. J. Sweep, J. W. M. Lenders, and P. Smits Antecedent Adrenaline Attenuates the Responsiveness to But Not the Release of Counterregulatory Hormones during Subsequent Hypoglycemia J. Clin. Endocrinol. Metab., November 1, 2003; 88(11): 5462 - 5467. [Abstract] [Full Text] [PDF]

				S. Enoksson, S. K. Caprio, F. Rife, G. I. Shulman, W. V. Tamborlane, and R. S. Sherwin Defective Activation of Skeletal Muscle and Adipose Tissue Lipolysis in Type 1 Diabetes Mellitus during Hypoglycemia J. Clin. Endocrinol. Metab., April 1, 2003; 88(4): 1503 - 1511. [Abstract] [Full Text] [PDF]